T
Takahide Sano
Researcher at Toho University
Publications - 5
Citations - 50
Takahide Sano is an academic researcher from Toho University. The author has contributed to research in topics: Retrospective cohort study & Odds ratio. The author has an hindex of 1, co-authored 5 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors.
Shingo Matsumoto,Shunsuke Kuroda,Takahide Sano,Takeshi Kitai,Taishi Yonetsu,Shun Kohsaka,Sho Torii,Takuya Kishi,Issei Komuro,Ken-ichi Hirata,Koichi Node,Yuya Matsue +11 more
TL;DR: In this paper, the effects of age on the outcomes of coronavirus disease 2019 (COVID-19) and on cardiac biomarker profiles, especially in patients with cardiovascular diseases and/or risk factors (CVDRF), were investigated.
Journal ArticleDOI
External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors.
Shunsuke Kuroda,Shingo Matsumoto,Takahide Sano,Takeshi Kitai,Taishi Yonetsu,Shun Kohsaka,Sho Torii,Takuya Kishi,Issei Komuro,Ken-ichi Hirata,Koichi Node,Yuya Matsue +11 more
TL;DR: In this paper, the 4C Mortality Score was proposed to predict in-hospital mortality in patients with COVID-19 and cardiovascular disease or coronary risk factors in 49 hospitals in Japan.
Journal ArticleDOI
Association Between Statin Use Prior to Admission and Lower Coronavirus Disease 2019 (COVID-19) Severity in Patients With Cardiovascular Disease or Risk Factors.
Yuji Ikari,Yuya Matsue,Sho Torii,Misaki Hasegawa,Kazuki Aihara,Shunsuke Kuroda,Takahide Sano,Takeshi Kitai,Taishi Yonetsu,Shun Kohsaka,Takuya Kishi,Issei Komuro,Ken-ichi Hirata,Koichi Node,Shingo Matsumoto +14 more
TL;DR: In this article, the potential benefits of statins use against severe coronavirus disease 2019 (COVID-19) were investigated in 693 patients with CVDRF from the CLAVIS-COVID database.
Journal ArticleDOI
Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors ― Insights From a Nationwide Japanese Cohort Study ―
Naofumi Yoshida,Sachiyo Iwata,Masato Ogawa,Kazuhiro P. Izawa,Shunsuke Kuroda,Shun Kohsaka,Taishi Yonetsu,Takeshi Kitai,Sho Torii,Takahide Sano,Yoshitada Sakai,Tomoya Yamashita,Ken-ichi Hirata,Yuya Matsue,Shingo Matsumoto,Koichi Node +15 more
TL;DR: In this paper, a post hoc analysis was performed of 693 Japanese COVID-19 patients with CVDRF enrolled in the nationwide CLAVIS-COVID registration system between January and May 2020 (mean [±SD] age 68.3±14.9 years; 35% female); 199 patients (28.7%) required ICU management.
Journal ArticleDOI
Multiple Cardiovascular Diseases or Risk Factors Increase the Severity of Coronavirus Disease 2019.
Tomoyuki Yamada,Taku Ogawa,Kenta Minami,Yusuke Kusaka,Masaaki Hoshiga,Akira Ukimura,Takahide Sano,Takeshi Kitai,Taishi Yonetsu,Sho Torii,Shun Kohsaka,Shunsuke Kuroda,Koichi Node,Yuya Matsue,Shingo Matsumoto +14 more
TL;DR: In this paper, a study aimed to determine whether disease severity varied according to whether coronavirus disease 2019 (COVID-19) patients had multiple or single cardiovascular diseases and risk factors (CVDRFs).